Skip to main content
. 2021 Apr 29;184(9):2348–2361.e6. doi: 10.1016/j.cell.2021.02.037

Figure 4.

Figure 4

Neutralization by potent mAbs

(A) Neutralization curves for Victoria and B.1.351 using 22 human monoclonal antibodies (mAbs).

(B) Neutralization curves of Victoria and B.1.351 strains using mAb pairs from Regeneron and AstraZeneca. The data underpinning the Victoria neutralization curves have been previously reported (Supasa et al., 2021). Individual FRNT50 values are shown in Table S3.